[Acute alveolitis due to mesalazine].
A 66-year-old male developed lymphocytic alveolitis with bronchiolitis after 3 month's treatment with mesalazin for ulcerative colitis. The patient's symptoms disappeared after halting mesalazin and increasing the steroid dose, the reduced diffusing capacity ameliorated and the thoracic X-ray normalized. The question whether this was a case of pulmonary involvement in inflammatory bowel disease or a drug side effect.
Lagler
U
U
Schweizerische Arzneimittel-Nebenwirkungs-Zentrale, SANZ, Chur.
Schulthess
H K
HK
Kuhn
M
M
D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000139:chemically induced* / Q000503:physiopathology; D000636:Aminosalicylic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D001988:Bronchiolitis / Q000139:chemically induced; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D008297:Male; D019804:Mesalamine; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects
D000636:Aminosalicylic Acids; D019804:Mesalamine
Akute Alveolitis unter Mesalazin.